An Open-Label, Multicenter Evaluation of Safety, Pharmacokinetics, and Efficacy of rFVIII in the Prevention and Treatment of Bleeding Episodes in Chinese With Hemophilia A
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Factor VIII (Primary)
- Indications Haemophilia A
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Chia Tai Tianqing Pharmaceutical Group
- 18 Oct 2016 New trial record